These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29341067)

  • 1. Vitamin E for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000209. PubMed ID: 29341067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; McGrath J
    Cochrane Database Syst Rev; 2011 Feb; (2):CD000209. PubMed ID: 21328246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
    Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Bergman H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J; Ogawa Y; Shinohara K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000208. PubMed ID: 29552749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines for antipsychotic-induced tardive dyskinesia.
    Bergman H; Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000205. PubMed ID: 29352477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2001; (4):CD000209. PubMed ID: 11687073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic medication for antipsychotic-induced tardive dyskinesia.
    Tammenmaa-Aho I; Asher R; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000207. PubMed ID: 29553158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000209. PubMed ID: 10796508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
    Deng H; Xu J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Rifai A
    Cochrane Database Syst Rev; 2011 Apr; (4):CD000203. PubMed ID: 21491376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
    Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia.
    Bergman H; Walker DM; Nikolakopoulou A; Soares-Weiser K; Adams CE
    Health Technol Assess; 2017 Aug; 21(43):1-218. PubMed ID: 28812541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.